v.krastev
TL2 · Gdańsk
Contributes reviews on supplier material. Based in Gdańsk.
Joined 29 April 2025 · last posted 15d
75 posts, newest first. Showing up to 150.
-
What is genuinely unknown about long-term amylin agonism Replied, post #31 · Compounds › Cagrilintide & amylin analogues · 13 Jul 2026 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Cagrilintide is a long-acting amylin analogue, which puts it in a different…
-
The headache that turns out to be dehydration — the long version Replied, post #59 · Nutrition & Training › Hydration & electrolytes · 30 Jun 2026 · 0 likes Reading back through, this was answered upthread and I missed it. My fault.
-
Endotoxin and why it is a separate question from purity — what changed since Replied, post #54 · Analytics › Impurities & related substances · 22 Jun 2026 · 0 likes Residual solvents: traces of solvents used in purification. These are usually tested by gas chromatography, not by HPLC. A specification for residual solvents should be…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #33 · Sourcing › Independent verification · 21 Jun 2026 · 4 likes Worth separating two things that post #29 runs together. I disagree with the framing of Interpreting a result above, and I think it is a substantive disagreement rather…
-
[2026 update] Area percent versus weight percent: the confusion that causes most arguments Replied, post #58 · Analytics › HPLC & UHPLC · 15 Jun 2026 · 18 likes If two laboratories disagree by more than two or three percentage points, work through method, integration, sample handling, whether it was the same lot and the same…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #17 · Access › Insurance & coverage · 12 Jun 2026 · 5 likes I read the earlier replies on Prior authorisation twice before writing this, because I had assumed the opposite and wanted to be sure I was disagreeing with what was…
-
Coming back to: Time to steady state after a dose increase Replied, post #74 · Pharmacology › Pharmacokinetics · 11 Jun 2026 · 4 likes A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model…
-
Designing a personal experiment that could change your mind — one year on Replied, post #58 · Research Methods › N-of-1 designs · 9 Jun 2026 · 0 likes Designing a personal experiment that could actually change your mind: that is the standard for an n-of-1 design. An experiment designed so that any result confirms what…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #129 · Practice › Storage & stability · 6 Jun 2026 · 2 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #110 · Compounds › Tirzepatide · 31 May 2026 · 27 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
Batch numbers that do not match the vial label — what changed since Replied, post #20 · Sourcing › Red flags · 23 May 2026 · 0 likes The guidelines draw that line for a practical reason as much as a fair one: reports accumulate into something useful and allegations do not. Posted with less confidence…
-
Reading a trial's population section before its results Replied, post #5 · Evidence › Trials · 7 May 2026 · 20 likes Taking post #2 at face value and following it one step further. The first question about any trial is what it set out to estimate, not what it found. Once the estimand…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #89 · Practice › Interactions · 20 Apr 2026 · 5 likes The most defensible general position in this subcategory: identify the plausible mechanism, check whether it has been studied, and where it has not, say that rather…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #68 · Practice › Side effects · 14 Apr 2026 · 11 likes An update on my earlier Dizziness on standing post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Stepping down deliberately, and how to do it without losing progress Replied, post #81 · Practice › Dosing & titration · 27 Mar 2026 · 14 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. A…
-
Managing an unplanned gap in supply Replied, post #72 · Access › Shortages · 24 Mar 2026 · 0 likes Resuming after a gap: after a gap of days or a few weeks, most people resume at the dose they were on when they stopped. Gaps of months might require retitration…
-
Anaesthesia and elective surgery: the aspiration question Replied, post #60 · Practice › Interactions · 23 Mar 2026 · 10 likes Narrowing post #57, because the general version has more than one answer. The reason anaesthesia and elective surgery keeps being re-asked is that the answer is…
-
Second pass at: Identical chromatograms across two different lots Replied, post #76 · Sourcing › Red flags · 18 Mar 2026 · 2 likes Reading rather than answering, but this is the post I would point somebody at.
-
Measurement error in home scales, with a worked standard deviation Replied, post #24 · Research Methods › Statistics · 14 Mar 2026 · 30 likes Picking up post #21: that is the part I would want checked first. Least significant change is the concept that makes measurement precision usable. Below it, a…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #54 · Compounds › Repair & healing peptides · 13 Mar 2026 · 3 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
-
Joined after a search result and stayed Started this topic · Lounge › Introductions · 10 Mar 2026 · 7 likes Posting this under the heading it deserves: Joined after a search result and stayed Everything below is what sits behind that. Saying hello, and stating my interest so…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #61 · Regional › UK & Ireland · 2 Mar 2026 · 2 likes Following this. I have the same question and no better information than the first post.
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #102 · Compounds › Oral incretins · 19 Feb 2026 · 12 likes The claim about SOUL trial and oral semaglutide upthread is stronger than its source supports. I have read the source. The source says "associated with" and the post…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #59 · Evidence › Study critique · 16 Feb 2026 · 8 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary.…
-
Research-use-only labelling: what it means and what it does not Replied, post #99 · Sourcing › Regulatory · 7 Feb 2026 · 3 likes Everything in post #97 holds. The case it does not cover is the one I have. Research-use-only material is not approved for human use anywhere. That is a statement about…
-
Named, unnamed and unspecified impurities as regulatory categories Replied, post #5 · Analytics › Impurities & related substances · 25 Jan 2026 · 7 likes Reading rather than answering, but this is the post I would point somebody at.
-
A history of disordered eating: proceeding carefully Replied, post #72 · Wellbeing › Mental health · 24 Jan 2026 · 8 likes A note on scope: what I am saying about history of disordered eating applies to the case in the first post and I would not extend it further without checking.
-
The headache that turns out to be dehydration Replied, post #143 · Nutrition & Training › Hydration & electrolytes · 18 Jan 2026 · 9 likes The version of headache that circulates here is a simplification of a simplification. It is not wrong, but it has lost the conditions under which it holds, and those…
-
A partial dose because the pen emptied mid-injection Replied, post #13 · Practice › Administration · 7 Jan 2026 · 12 likes The useful distinction on partial dose because the pen is between what was measured and what was inferred from it. Both end up in the same sentence and only one of them…
-
Request: a diff view for wiki revisions — the long version Replied, post #94 · Meta › Feature requests · 4 Jan 2026 · 2 likes Following, with nothing to contribute beyond having asked the same thing elsewhere.
-
Coming back to: Private prescribing in the UK: what is actually involved Replied, post #27 · Regional › UK & Ireland · 31 Dec 2025 · 3 likes Everything in post #26 holds. The case it does not cover is the one I have. I would be cautious about generalising from the Private prescribing example above. It is a…
-
Angle of injection and whether 90 degrees is always right Replied, post #60 · Practice › Administration · 4 Dec 2025 · 18 likes This follows post #59 rather than contradicting it. If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a…
-
Reading an interaction checker output critically Replied, post #48 · Practice › Interactions · 21 Nov 2025 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular…
-
Micro-titration: a disputed topic, argued properly Replied, post #3 · Practice › Dosing & titration · 13 Nov 2025 · 25 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose. I…
-
Run-in periods and the population they select Replied, post #21 · Evidence › Trials · 12 Nov 2025 · 26 likes Adding the measurement that post #19 says would settle it. Trying to state the run-in periods position in a way that someone who disagrees would recognise as fair,…
-
High-resolution MS on aggregates and what it can see Replied, post #115 · Analytics › Mass spectrometry · 8 Nov 2025 · 0 likes This follows post #113 rather than contradicting it. An observation about high-resolution that I cannot explain and am posting anyway, on the principle that unexplained…
-
How to ask about something you suspect is a bad idea Replied, post #17 · Start Here › How to Ask · 18 Oct 2025 · 10 likes Adding the measurement that post #16 says would settle it. Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done…
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #83 · Practice › Storage & stability · 5 Oct 2025 · 24 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #106 · Evidence › Preprints · 3 Oct 2025 · 2 likes Author track record is a weak signal and it is a signal. A group that has published carefully for years is a different prior from an unknown one. That distinction has…
-
Citing a preprint in a maintained document: our rule and its reasoning — does this still… Replied, post #84 · Evidence › Preprints · 2 Oct 2025 · 22 likes Picking up post #81: that is the part I would want checked first. What changes between preprint and publication: authors respond to reviewer comments, re-analyse data,…
-
Second pass at: Programming during a large energy deficit Replied, post #18 · Nutrition & Training › Resistance training · 25 Sep 2025 · 1 like Strength and hypertrophy respond to different things, and preserving one during a deficit is a different objective from building the other. The answer changed when I…
-
Reading a supplier's product description as a marketing document Replied, post #73 · Compounds › Other compounds · 20 Sep 2025 · 0 likes Nicotinamide adenine dinucleotide preparations are not peptides at all and the certificate conventions are completely different. Reading one as though it were a peptide…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #59 · Practice › Administration · 13 Sep 2025 · 0 likes Bleeding at the injection site: normal and usually minimal. A little blood at the needle site after withdrawal is not a reason to assume you lost a significant dose.…
-
Airline travel with a temperature-sensitive injectable Started this topic · Devices › Cold chain · 2 Sep 2025 · 2 likes Posting this under the heading it deserves: Airline travel with a temperature-sensitive injectable Everything below is what sits behind that. Airline travel: setting…
-
Where the integrator drew the baseline, and how much it moved the number Replied, post #4 · Analytics › HPLC & UHPLC · 21 Aug 2025 · 1 like Integrator would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Titles that describe the question, not the situation Replied, post #73 · Start Here › How to Ask · 17 Aug 2025 · 0 likes Building on post #70 rather than restating it. Titles: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the…
-
A preprint whose numbers changed substantially at publication Replied, post #12 · Evidence › Preprints · 7 Aug 2025 · 0 likes Where a preprint contradicts a published trial, the prior should favour the trial. Where it extends one, the preprint can be genuinely useful. The confident version of…
-
What a documentation review can and cannot tell you Replied, post #56 · Sourcing › Independent verification · 1 Aug 2025 · 2 likes A request rather than an answer: could whoever has the primary source for documentation review post it? I have seen the claim three times this month and each version…
-
Guidelines revision: what changed and why — one year on Replied, post #3 · Meta › Announcements · 25 Jul 2025 · 15 likes Post #2 is the version of this I will quote in future. One addition. I would keep Guidelines revision and the decision it usually gets used for separate in this thread.…
-
Coming back to: When "no data" is the complete and final answer Replied, post #55 · Compounds › Other compounds · 22 Jul 2025 · 2 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
-
BPC-157: what the rodent literature actually shows, and what it does not Replied, post #21 · Compounds › Repair & healing peptides · 20 Jul 2025 · 19 likes TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The two are routinely conflated in supplier documentation…
-
Trial registration and comparing the protocol with the paper Replied, post #13 · Evidence › Trials · 8 Jun 2025 · 0 likes Entry criteria, run-in periods and the self-selection of people willing to enter a multi-year trial all narrow the population. That is how internal validity is bought…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #99 · Wellbeing › Mental health · 7 Jun 2025 · 15 likes Answering the question post #95 raises rather than the one it answers. Two people in this thread mean different things by anxiety and are disagreeing about the…
-
Pre-registering a personal experiment, seriously Replied, post #79 · Research Methods › N-of-1 designs · 1 Jun 2025 · 21 likes A note on scope: what I am saying about pre-registering a personal experiment applies to the case in the first post and I would not extend it further without checking.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #114 · Practice › Reconstitution · 23 May 2025 · 1 like Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Asking about a compound your prescriber has not heard of Replied, post #42 · Clinical › Prescriber conversations · 18 May 2025 · 8 likes Written summaries after an appointment are available in many systems and are worth asking for, because recollection of a consultation is unreliable. Two people can read…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #52 · Compounds › Tirzepatide · 10 May 2025 · 4 likes Post #51 and I disagree about the size of the effect, not about the direction. On the mechanism question specifically: the honest position is that GIP agonism plausibly…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #129 · Documentation › Doc review · 28 Apr 2025 · 3 likes Review the scope as well as the content. A page attempting too much is the commonest structural problem at this stage. That matches what I was told, which is not the…
-
Washout: how long is long enough, and for what purpose Replied, post #17 · Pharmacology › Pharmacokinetics · 11 Apr 2025 · 9 likes Since washout keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct experience…
-
Second pass at: A single out-of-range value on an otherwise normal panel Replied, post #9 · Clinical › Bloodwork · 6 Mar 2025 · 2 likes Nothing in this subcategory is medical advice, and a panel with an unexpected result is precisely the situation where that matters.
-
Consistent declarations and why they matter more than clever ones Started this topic · Sourcing › Logistics · 5 Feb 2025 · 30 likes Consistent declarations and why they matter more than clever ones — setting out what I have, and where I think it stops being reliable. A follow-up question about…
-
Why we hide unevidenced fraud accusations and log the hiding Replied, post #30 · Sourcing › Red flags · 24 Dec 2024 · 11 likes Second this, and I would have said it less carefully.
-
Building a sensible monitoring schedule with your prescriber Replied, post #48 · Clinical › Bloodwork · 20 Dec 2024 · 26 likes Confirming post #45 from a second method, which matters more than confirming it from a second person. A trend needs at least three points to be a trend. Two points are…
-
What we do not know about retatrutide, listed explicitly Replied, post #19 · Compounds › Retatrutide · 12 Dec 2024 · 0 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
[2026 update] New subcategory: rationale and scope Replied, post #25 · Meta › Announcements · 26 Nov 2024 · 26 likes One more thing on New subcategory that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
-
Why pulsatile secretion matters for interpreting secretagogue claims — a second dataset Replied, post #22 · Compounds › Secretagogues & GH axis · 14 Nov 2024 · 32 likes Summarising the pulsatile secretion thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the correction to it, and…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #30 · Compounds › Tirzepatide · 10 Nov 2024 · 0 likes Categorical response thresholds — the proportion reaching ten, fifteen or twenty per cent reduction — are more persuasive and less informative than the mean. They…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #15 · Sourcing › Regulatory · 23 Oct 2024 · 5 likes What I can speak to on Research-use-only labelling is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
Irish differences from the UK position Replied, post #38 · Regional › UK & Ireland · 14 Oct 2024 · 30 likes Pharmacy practice varies between pharmacies and is not deducible from the regulatory position. Two people can honestly report opposite experiences. I looked this up…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #54 · Clinical › Bloodwork · 24 Sep 2024 · 7 likes Repeat before acting is standard practice for an isolated abnormal result on most analytes, and it is standard for a reason.
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #99 · Nutrition & Training › Hydration & electrolytes · 17 Sep 2024 · 5 likes Potassium: similar to sodium; losing weight involves some potassium loss. Bananas, sweet potatoes, and other potassium-rich foods help. Severe depletion is rare but…
-
Circumference measurements as a poor man's composition estimate Replied, post #107 · Outcomes › Body composition · 29 Aug 2024 · 6 likes Comparing a body composition result against a population reference is a different exercise from tracking your own change, and the second is what most people want.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #53 · Analytics › COA interpretation · 12 Aug 2024 · 16 likes The signature block matters more than it appears to. A named individual with a date is a different kind of document from an unsigned one, whatever the numbers say.…
-
Cold packs, phase-change material, and what survives ten days Replied, post #16 · Sourcing › Logistics · 15 Jun 2024 · 0 likes Nothing in this subcategory is legal advice, and the legal position on importing research-use-only material varies by jurisdiction and is yours to establish. I am aware…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #13 · Practice › Dosing & titration · 14 Jun 2024 · 1 like Adding the measurement that post #10 says would settle it. Nothing here is medical advice, and a titration question is one of the few where a prescriber can genuinely…